Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: Correlation with morphology

Cancer

Volumn 88, Issue 4, 2000, Pages 894-899

  Duggan, Peter R ^a   Easton, David ^a,b   Luider, Joanne ^b   Auer, Iwona A ^b,c  

^a Department of Medicine   (Canada)

^b CALGARY LABORATORY SERVICES   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; BONE MARROW BIOPSY; CANCER STAGING; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; MORPHOLOGY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ANTIGENS, CD; BIOPSY; BONE MARROW; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, NON-HODGKIN; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 0034651672     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000215)88:4<894::AID-CNCR21>3.0.CO;2-O     Document Type: Article

References (22)

1. Coller BS, Chabner BA, Gralnick HR. Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsies. Am J Hematol 1977;3:105-19.
2. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: the Non-Hodgkin's Lymphoma Classification Project. Blood 1997;89: 3909-18.
3. Bennett JM, Cain KC, Glick JH, Johnson GJ, Ezdinli E, O'Connell MJ. The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience. J Clin Oncol 1986;4:1462-9.
4. Connors JM, Klimo P, Fairey RN, Voss N. Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med 1987; 107:25-30.
5. LaCombe MA, Mittal BB, Colangelo LA, Rademaker AW, Brand WN, Kim H, et al. Management of early-stage Hodgkin's lymphoma: the radiation oncology experience at Northwestern University/Northwestern Memorial Hospital. Am J Clin Oncol 1996;19:235-40.
6. Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM, Grogan TM, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-and high-grade non-Hodgkin's lymphoma. N Engl J Med 1998;339:21-6.
7. Mac Manus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996;14:1282-90.
8. Besa PC, McLaughlin PW, Cox JD, Fuller LM. Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma. Cancer 1995; 75:2361-7.
9. Mac Manus MP, Rainer Bowie CA, Hoppe RT. What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma? Int J Radiat Oncol Biol Phys 1998;42:365-71.
10. Fineherg S, Marsh E, Alfonso F, Espiritu E, Gottesman SR, Amorosi F, et al. Immunophenotypic evaluation of the bone marrow in non-Hodgkin's lymphoma. Hum Pathol 1993;24: 636-42.
11. Naughton MJ, Hess JL, Zutter MM, Bartlett NL. Bone marrow staging in patients with non-Hodgkin's lymphoma: is flow cytometry a useful test? Cancer 1998;82:1154-9.
12. Dunphy CH. Combining morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasms. Am J Clin Pathol 1998;109: 625-30.
13. McKenna RW, Hernandez JA. Bone marrow in malignant lymphoma. Hematol Oncol Clin North Am 1988;2:617-35.
14. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999;17:1244-53.
15. Rappaport H, Berard CW, Butler JJ, Dorfman RF, Lukes RJ, Thomas LB. Report of the Committee on Histopathological Criteria Contributing to Staging of Hodgkin's Disease. Cancer Res 1971;31:1864-5.
16. Stewart CC, Behm FG, Carey JL, Cornbleet J, Duque RE, Hudnall SD, et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. Cytometry 1997;30:231-5.
17. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
18. Tbakhi A, Edinger M, Myles J, Pohlman B, Tubbs RR. Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders. Cytometry 1996;25:113-24.
19. Luoni M, Declich P, De Paoli A, Fava S, Marinoni P, Montalbetti L, et al. Bone marrow biopsy for the staging of non-Hodgkin's lymphoma: bilateral or unilateral trephine biopsy? Tumori 1995;81:410-3.
20. Juneja SK, Wolf MM, Cooper IA. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. J Clin Pathol 1990;43:630-2.
21. Pittaluga S, Tierens A, Dodoo YL, Delabie J, De Wolf-Peeters C. How reliable is histologic examination of bone marrow trephine biopsy specimens for the staging of non-Hodgkin lymphoma? A study of hairy cell leukemia and mantle cell lymphoma involvement of the bone marrow trephine specimen by histologic, immunohistochemical, and polymerase chain reaction techniques. Am J Clin Pathol 1999;111:179-84.
22. Coad JE, Olson DJ, Christensen DR, Lander TA, Chibbar R, McGlennen RC, et al. Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas. Am J Surg Pathol 1997;21: 1047-56.